Notable Labs Presents Clinical Platform Validation Data at the 2023 American Association for Cancer Research Annual Meeting – 100% accuracy predicting clinical responders with Notable’s PPMP with enhanced machine learning – – Fourth clinical validation study of Predictive Precision Medicine Platform FOSTER CITY, Calif., April 18, 2023 – Notable Labs, Inc. (“Notable”), a clinical stage […]
April 18, 2023
The merger agreement can be viewed from the link below: Merger Agreement
February 23, 2023
Published 10/18/2022 Link to: https://www.pharmatechoutlook.com/notable-labs
October 21, 2022
Published 9/25/2022 In support of the MDS Foundation, Notable Labs took part in the “Move for MDS Walk”, a 5-cities event that brings together patients, family members and caregivers in the MDS community. Matt de Silva, Notable’s Founder and Executive Chairman, joined the event from Chicago, IL at Maggie Daley Park on September 25, 2022. […]
September 25, 2022
Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology. Meagan Parrish, Lead Editor PharmaVoice Published May 2, 2022 – Many pharma execs find that a personal experience with a patient serves as a catalyst to enter the field. For Dr. Thomas Bock, CEO of […]
May 4, 2022
The merger deck can be downloaded from the link below: Notable Labs & VBL Merger Deck
February 23, 2023
Webcast Join our public webcast by clicking on the link below: https://viavid.webcasts.com/starthere.jsp?ei=1600185&tp_key=4b7262a51e Phone (877) 407-9208 (U.S. and Canada) or (201) 493-6784 (international) Passcode: 13736622
February 23, 2023
Link below: Roth Conference 2022 Video
January 6, 2023
October 14 - 15, 2022 | New York, NY
June 29, 2022
Notable Labs Presents Clinical Platform Validation Data at the 2023 American Association for Cancer Research Annual Meeting – 100% accuracy predicting clinical responders with Notable’s PPMP with enhanced machine learning – – Fourth clinical validation study of Predictive Precision Medicine Platform FOSTER CITY, Calif., April 18, 2023 – Notable Labs, Inc. (“Notable”), a clinical stage […]
April 18, 2023
The merger deck can be downloaded from the link below: Notable Labs & VBL Merger Deck
February 23, 2023
The merger agreement can be viewed from the link below: Merger Agreement
February 23, 2023
Industry Dealmaker Joins Notable to Accelerate In-licensing Strategy to Fuel Predictive Precision Platform and Pipeline Foster City, Calif., January 6, 2021 – Notable Labs, Inc. (Notable), a clinical-stage platform therapeutics company, announced the appointment of Kevin Lynch, Ph.D., M.B.A, as Chief Business Officer. Dr. Lynch has decades of deal-making experience within pharma, and recently led […]
January 6, 2022
Studies demonstrate high correlation between predicted response by Notable’s predictive precision medicines platform and actual clinical response, short-term and at one year Interim analyses of studies with MD Anderson Cancer Center and Texas Children’s Hospital investigators corroborate platform prediction data from Standford University collaboration Foster City, Calif., December 16, 2021 – Notable Labs, Inc. (Notable), […]
December 16, 2021
Notable Will Leverage Its High-Fidelity Predictive Precision Medicines Platform With The Goal Of Assessing Patient Responsiveness To Fosciclopirox Foster City, Calif. and Kansas City, Mo., December 1, 2021 – Notable Labs, Inc. (Notable), a clinical-stage predictive precision therapeutics company and CicloMed LLC (CicloMed), a developmental-stage pharmaceutical company have initiated a Phase 1B/2A clinical trial of […]
December 1, 2021
Foster City, Calif., November 23, 2021 – Notable Labs, Inc. (Notable), a clinical-stage platform therapeutics company designing and delivering predictive precision medicines, today announced the appointment of Chris Whitmore as Chief Financial Officer. In this role, Mr. Whitmore will be a key member of the executive leadership team and will lead Notable’s financial strategy, planning […]
November 23, 2021
Notable Will Leverage Its High-Fidelity Predictive Precision Medicines Platformto Accelerate Clinical Development and Maximize Patient Outcomes Foster City, Calif., November 22, 2021 – Notable Labs, Inc. (Notable), a clinical-stage platform therapeutics company, today announced two abstracts have been accepted for poster presentation at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition. “These two clinical […]
November 22, 2021
Notable Will Leverage Its High-Fidelity Predictive Precision Medicines Platform to Accelerate Clinical Trial Timelines and Maximize Patient Outcomes Volasertib is a PLK-1 inhibitor with therapeutic potential across a range of tumor types Foster City, Calif., November 11, 2021 – Notable Labs, Inc. (Notable), a pioneer and developer of predictive precision medicines, has obtained worldwide rights […]
November 11, 2021
FOSTER CITY, CA – June 10, 2021 — Notable Labs Inc., a leader in technology-powered life science with a proprietary platform for predicting patient outcomes and accelerating precision drug development, today announced that it will be attending BIO Digital 2021, a key international biotech partnering event held virtually on June 14-18. During the conference Notable […]
June 10, 2021
FOSTER CITY, CA – June 4, 2021 — Notable Labs Inc., a leader in technology-powered life science with a proprietary platform for predicting patient outcomes and accelerating precision drug development, today announced top-line results from its clinical response prediction technology platform in a pediatric acute myeloid leukemia (AML) study to be presented at the 2021 […]
June 4, 2021
FOSTER CITY, CA – March 31, 2021 – Notable Labs Inc., a leader in technology-powered life science with a proprietary platform for predicting patient outcomes and accelerating precision drug development, today announced the appointment of Thomas A. Bock, MD, MBA, as Chief Executive Officer.
March 31, 2021
FOSTER CITY, CA – January 26, 2021 – Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced that it is hosting a live webinar on February 9th to unveil their integrative data platform.
January 27, 2021
FOSTER CITY, CA – January 8, 2021 – Notable Labs, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced that it is participating in Biotech Showcase™ 2021 and will be presenting the strategic plan for long-term growth.
January 8, 2021
FOSTER CITY, CA – Dec 3, 2020 – Dr. Michael Spinner, from Stanford University, Department of Medicine, Division of Oncology, will present at the 2020 Virtual ASH Annual Meeting an update to the recently published article in Blood Advances.
December 6, 2020
FOSTER CITY, CA and SEATTLE; Oct. 28, 2020 (Business Wire) – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, and All4Cure, which has built a real world data powered network of patients, clinicians and researchers to dramatically improve outcomes for millions of patients with cancer, today announced their partnership.
October 28, 2020
FOSTER CITY, CA – Oct. 13, 2020 – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Thomas A. Bock to its board of directors.
October 12, 2020
FOSTER CITY, CA – Sep. 24, 2020 – Notable, a functional precision medicine company, and myTomorrows, an integrated platform that links patients with an unmet medical need to treatments in development worldwide, are proud to announce their partnership.
September 24, 2020
FOSTER CITY, CA – Aug. 06, 2020 – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced a new precision oncology study with Washington University School of Medicine in St. Louis, exploring the feasibility of ex vivo drug screening to predict sensitivity and resistance to chemotherapy, and to identify novel synergies across a broad panel of anti-cancer therapies.
August 6, 2020
FOSTER CITY, CA – July 08, 2020 (GLOBE NEWSWIRE) – Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today that Joseph Wagner, PhD, has joined the company as Chief Scientific Officer. Dr. Wagner.
July 8, 2020
FOSTER CITY, CA – June 23, 2020 (GLOBE NEWSWIRE) — Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, announced today that the results of a Stanford study using its drug sensitivity screening platform have been published in Blood Advances (June 23, 2020; Volume 4, Issue 12).
June 23, 2020
FOSTER CITY, CA – April 30, 2020 — Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, announced a partnership today with the MDS Foundation. MDS Foundation (MDSF) provides insight and information to families on upcoming clinical trials for myelodysplastic syndrome (MDS). As part of the partnership, Notable […]
April 30, 2020
FOSTER CITY, CA – April 09, 2020 (GLOBE NEWSWIRE) — Notable, a technology leader redefining cancer treatment through rapid drug development via a clinically validated platform, announced today its board has appointed veteran life science executive Laurie Heilmann as Chief Executive Officer. She succeeds founder Matt De Silva who will remain a member of Notable’s […]
April 9, 2020
FOSTER CITY, CA – January 22, 2020 — Notable, which is redefining cancer treatment with its scientific technology platform to rapidly advance drug development, is launching its first self-sponsored clinical trial, designed from the ground up to help validate its cancer patient matching platform over the long term.
January 22, 2020
The 50 best workplaces for innovators
by fastcompany.com
Notable Named To Fast Company’s Inaugural List Of The 50 Best Workplaces for Innovators
by globenewswire.com
Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round
by genomeweb.com
Personalized cancer treatment startup Notable Labs nabs $40M Series B
by Kevin Truong
by Natalie Grover
Notable raises $40 million to personalize cancer drug regimens
by Kyle Wiggers
Notable Labs lands $40M to expand AI-based cancer treatment tech
by Amirah Al Idrus
July 16, 2019
Blood cancer startup targets treatment personalization
By Hannah Norman
Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer
By MedCity News
Notable Labs brings on 2 development executives ahead of its first blood cancer trials
By fiercebiotech.com
Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing NonProfit
By globenewswire.com
By globenewswire.com
The Leukemia & Lymphoma Society Presents Man & Woman of the Year
By mwoy.org
Tech investors take a Warren Buffett approach to raising money for blood cancer research
By cnbc.com May 19, 2018
In the next few weeks, you can spend time with any one of these VCs and it will all go to charity
By techcrunch.com on May 17, 2018
Here’s the Problem with Today’s Human Clinical Trials
By fortune.com on March 20, 2018
Builders VC Backs Personalized Cancer Treatment
By wsj.com on September 06, 2017
Notable Labs Raises $10M in Series A
By 360dx.com on September 06, 2017
Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists
By medcitynews.com on September 06, 2017
Notable Labs nets $10M for personalized cancer treatment tech
By fiercebiotech.com on September 06, 2017
Notable Labs Raises $10 Million Series A Financing to Advance Personalized Cancer Treatments
By businesswire.com on September 06, 2017
By tetrascience.com on June 15, 2017
A High Throughput Screening System to Identify Actionable Treatments for Cancer Patients
By biosero.com on June 15, 2017
These seven researchers are changing the face of biotech
By bizjournals.com on June 8, 2017
Interview: Notable Labs tackles cancer research with cutting-edge tech
By tetrascience.com on June 12, 2017
ELITE Tech-Know Geek Transon Nguyen of Notable Labs
By pm360online.com on May 22, 2017
ELITE Disrupter Matthew De Silva of Notable Labs
By pm360online.com on May 22, 2017
By pm360online.com on May 21, 2017
Labcyte Announces Collaboration with Notable Labs to Apply Functional Cancer Cell Screening
By labcyte.com on Dec 7, 2016
By robotics.org on Nov 17, 2016
By intellicyt.com on Jun 20, 2016
Biden Comes To Silicon Valley For Innovation In White House Cancer Moonshot Initiative
By TechCrunch on Feb 27, 2016
By Forbes on Jan 4, 2016
How Scientists Can Thrive in the Startup World
By themacro.com on Nov 18, 2015
YC Alum Atomwise Raises $6 Million To Further The Advancement Of Artificial Intelligence In Drug Dis
By TechCrunch on Jun 3, 2015
A Look Inside Transcriptic’s New Biotech Testing Facility
By TechCrunch on Mar 25, 2015
Y Combinator demo-thon: Check out 5 favorites from Day 2 – Silicon Valley Business Journal
By Boston Tech Flash on Mar 25, 2015
The Top 10 Startups Of Y Combinator Winter ’15 Demo Day 2
By TechCrunch on Mar 25, 2015
47 Startups That Launched At Y Combinator Winter 2015 Demo Day 2
By TechCrunch on Mar 24, 2015
Y Combinator backs cancer drug combo testing service
By fiercebiotechit.com on Mar 13, 2015
YC-Backed Notable Labs Provides Personalized Medical Testing For Brain Cancer Patients
By TechCrunch on Mar 10, 2015
The 50 best workplaces for innovators
by fastcompany.com
Notable Named To Fast Company’s Inaugural List Of The 50 Best Workplaces for Innovators
by globenewswire.com
Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round
by genomeweb.com
Personalized cancer treatment startup Notable Labs nabs $40M Series B
by Kevin Truong
by Natalie Grover
Notable raises $40 million to personalize cancer drug regimens
by Kyle Wiggers
Notable Labs lands $40M to expand AI-based cancer treatment tech
by Amirah Al Idrus
July 16, 2019
Blood cancer startup targets treatment personalization
By Hannah Norman
Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer
By MedCity News
Notable Labs brings on 2 development executives ahead of its first blood cancer trials
By fiercebiotech.com
Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing NonProfit
By globenewswire.com
By globenewswire.com
The Leukemia & Lymphoma Society Presents Man & Woman of the Year
By mwoy.org
Tech investors take a Warren Buffett approach to raising money for blood cancer research
By cnbc.com May 19, 2018
In the next few weeks, you can spend time with any one of these VCs and it will all go to charity
By techcrunch.com on May 17, 2018
Here’s the Problem with Today’s Human Clinical Trials
By fortune.com on March 20, 2018
Builders VC Backs Personalized Cancer Treatment
By wsj.com on September 06, 2017
Notable Labs Raises $10M in Series A
By 360dx.com on September 06, 2017
Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists
By medcitynews.com on September 06, 2017
Notable Labs nets $10M for personalized cancer treatment tech
By fiercebiotech.com on September 06, 2017
Notable Labs Raises $10 Million Series A Financing to Advance Personalized Cancer Treatments
By businesswire.com on September 06, 2017
By tetrascience.com on June 15, 2017
A High Throughput Screening System to Identify Actionable Treatments for Cancer Patients
By biosero.com on June 15, 2017
These seven researchers are changing the face of biotech
By bizjournals.com on June 8, 2017
Interview: Notable Labs tackles cancer research with cutting-edge tech
By tetrascience.com on June 12, 2017
ELITE Tech-Know Geek Transon Nguyen of Notable Labs
By pm360online.com on May 22, 2017
ELITE Disrupter Matthew De Silva of Notable Labs
By pm360online.com on May 22, 2017
By pm360online.com on May 21, 2017
Labcyte Announces Collaboration with Notable Labs to Apply Functional Cancer Cell Screening
By labcyte.com on Dec 7, 2016
By robotics.org on Nov 17, 2016
By intellicyt.com on Jun 20, 2016
Biden Comes To Silicon Valley For Innovation In White House Cancer Moonshot Initiative
By TechCrunch on Feb 27, 2016
By Forbes on Jan 4, 2016
How Scientists Can Thrive in the Startup World
By themacro.com on Nov 18, 2015
YC Alum Atomwise Raises $6 Million To Further The Advancement Of Artificial Intelligence In Drug Dis
By TechCrunch on Jun 3, 2015
A Look Inside Transcriptic’s New Biotech Testing Facility
By TechCrunch on Mar 25, 2015
Y Combinator demo-thon: Check out 5 favorites from Day 2 – Silicon Valley Business Journal
By Boston Tech Flash on Mar 25, 2015
The Top 10 Startups Of Y Combinator Winter ’15 Demo Day 2
By TechCrunch on Mar 25, 2015
47 Startups That Launched At Y Combinator Winter 2015 Demo Day 2
By TechCrunch on Mar 24, 2015
Y Combinator backs cancer drug combo testing service
By fiercebiotechit.com on Mar 13, 2015
YC-Backed Notable Labs Provides Personalized Medical Testing For Brain Cancer Patients
By TechCrunch on Mar 10, 2015